Healthcare -
Biotechnology - NASDAQ - US
$ 3.79
49.2 %
$ 10.3 M
Market Cap
-1.82
P/E
CYCN - CAPITAL EXPENDITURES
Capital Expenditures CYCN - Cyclerion Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR